About this trial
Fever is a common symptom in many health conditions, but current methods to monitor body temperature (BT) are either invasive, costly, or not continuous. The Corsano CardioWatch 287-2, a wristband that tracks multiple vital signs, offers a new way to monitor BT by measuring skin temperature and heat flux on the wrist. It uses a machine learning algorithm to predict BT in real-time. The device has shown good results when compared to other non-invasive temperature measurements, like tympanic (ear) temperature, in stroke patients. However, it hasn't yet been compared to the gold standard of invasive rectal temperature monitoring in a clinical setting. This study aims to test the accuracy of the Corsano CardioWatch 287-2 in measuring body temperature against rectal temperature monitoring in a clinical environment.
Eligibility criteria
Qualifiers
≥ 18 years old;
Able to provide consent
Administered at the ICU or recovery room of the Reinier de Graaf hospita
Disqualifiers
Unable to wear the Corsano CardioWatch 287 or Radius-T sensor due to reasons such as allergic reactions, wounds, amputations etc.;
Unable to receive rectal temperature monitoring;
Thermoregulatory problems or diseases;
Hyperthermia (>40°C);
Trial design
Treatments tested in this trial
- Corsano CardioWatch 287-2